JYNT Stock Recent News

Joint Venture Represents First Major Step in U.S.-Based Manufacturing Joint Venture Represents First Major Step in U.S.-Based Manufacturing

Joint Venture Will Increase FTAI's Global Maintenance Capacity by Approximately 40% Joint Venture Will Increase FTAI's Global Maintenance Capacity by Approximately 40%

SCOTTSDALE, Ariz., June 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that its board of directors has authorized a stock repurchase program expected to begin in August 2025 under which the company may repurchase up to $5 million of its outstanding common stock.

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal health market Evaluation of AZD5658 expands Conduit's glucokinase activator platform into novel veterinary applications, complementing AZD1656 development Cost-efficient approach enhances Conduit's pipeline while preserving full ownership of intellectual property and data, maximizing shareholder value Synergistic combination therapies under evaluation could redefine treatment standards in veterinary and human applications NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 04, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”) today announced that it has entered into a joint development agreement with Manoira Corporation (“Manoira”), a privately held specialty animal health company specializing in proprietary reformulation technolog

- Accomplished Global HR Executive with Deep Franchise and Healthcare Expertise, including CHRO Roles at Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International, to Join Board - - Accomplished Global HR Executive with Deep Franchise and Healthcare Expertise, including CHRO Roles at Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International, to Join Board -

OSLO, Norway , June 3, 2025 /PRNewswire/ -- Agilyx ASA (OSE: AGLX) (OTCQX: AGXXF) announces its venture Plastyx Ltd. has reached 75% of its near-term objective to source and execute MOUs for 200,000 metric tons of waste plastic by the end of 2025.

Recycling feedstock such as EV motors, HDDs, wind turbines, MRI machines, and other permanent magnet-containing materials scaling to 2,000+ metric tons per annum The partnership brings together two companies from two nations that are dedicated to developing cost effective domestic supply chains for critical minerals and rare earth elements FISHERS, IN / ACCESS Newswire / June 3, 2025 / American Resources Corporation (NASDAQ:AREC) ("American Resources"), through its holding in ReElement Technologies Corporation ("ReElement" or "RTC"), a leading U.S. innovator in rare earth element (REE) and critical mineral refining, announced today that it has signed a memorandum of understanding (MOU) to enter into a joint venture agreement with Exigo Battery Solutions Pvt. Ltd. ("Exigo") to have the joint venture entity utilize ReElement's proprietary rare earth oxide refining technologies within the United States and in India along with Exigo's ability to source, process, and supply rare earth conce

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX: CSU) and Topicus.com Inc. (TSXV: TOI) today announced that Topicus' subsidiary Total Specific Solutions (TSS) B.V. (“TSS”) has completed the sale and transfer of all issued and outstanding shares in the capital of Cipal Schaubroeck NV to TSS.

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX: CSU) and Topicus.com Inc. (TSXV: TOI) today announced that Topicus' subsidiary Total Specific Solutions (TSS) B.V. (“TSS”) has completed the sale and transfer of all issued and outstanding shares in the capital of Cipal Schaubroeck NV to TSS.

BASFY is set to acquire full control of Alsachimie JV, boosting efficiency and deepening integration in PA 6.6 production at the Chalampe site.